Rs 570 cr seized from 3 containers by election officials in Tamil Nadu

Bengaluru, Jan 24: Karnataka High Court on Friday ordered notice to the state government and self-styled godman Swami Nithyananda while hearing a petition seeking cancellation of bail granted to him.

A petition was filed in the Karnataka High Court on Friday seeking cancellation of bail granted to Nithyananda for skipping the trial and fleeing the country.

Justice John Michael Cunha, after hearing the complainant, ordered issuance of notice to the state government and Nithyananda and posted the matter for hearing next week.

The petition, filed by K Lenin, alleged that Nithyananda has been skipping trial and has fled the country on an expired passport.

The plea further said that Nithyananda was making false representations in his "exemption petitions to the trial court as if he is still in India".

Interpol has also issued a 'blue corner notice' to locate the self-styled godman, who is facing trial in a criminal case, on the request of Gujarat Police. 

Bengaluru, Jun 17: The Opposition leader in the Karnataka Assembly Siddaramaiah on Wednesday strongly urged Chief Minister B S Yediyurappa to desist from invoking amendment to the Land Reforms Act, saying it would make buying land easier for the corporate companies and the rich.

In a hard-hitting letter to the Chief Minister, a copy of which was released to the media, the Congress leader had urged to rescind the decision from amending to the Karnataka Land Reforms Act and also Agriculture Produces Marketing Committee Act.

Asserting that the state government's move was only intending to help to the land grabbers, Siddaramaiah, also the former chief minister, said easing of restrictions to buy land to the tune of over 216 acres per individual would sound a death knell to the farm sector.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.